Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Medicinal Chemistry|April 23, 2021
From High-Throughput Screening to Target Validation: Benzo[<i>d</i>]isothiazoles as Potent and Selective Agonists of Human Transient Receptor Potential Cation Channel Subfamily M Member 5 Possessing In Vivo Gastrointestinal Prokinetic Activity in RodentsAlessio Barilli, Laura Aldegheri, Federica Bianchi, et al.Bioorganic & Medicinal Chemistry|March 9, 2016
1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonistsFabrizio Micheli, Andrea Bernardelli, Federica Bianchi, et al.European Journal of Medicinal Chemistry|September 14, 2019
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systemsAlessandro Grillo, Giulia Chemi, Simone Brogi, et al.Journal of Medicinal Chemistry|August 27, 2016
1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor AntagonistsFabrizio Micheli, Alessia Bacchi, Simone Braggio, et al.Bioorganic & Medicinal Chemistry Letters|April 17, 2012
Identification of a series of 1,3,4-oxadiazol-2-amines as potent alpha-7 agonists with efficacy in the novel object recognition model of cognitionJohn Skidmore, Zeenat Atcha, Emmanuelle Boucherat, et al.Bioorganic & Medicinal Chemistry Letters|April 17, 2012
The discovery of 2-fluoro-N-(3-fluoro-4-(5-((4-morpholinobutyl)amino)-1,3,4-oxadiazol-2-yl)phenyl)benzamide, a full agonist of the alpha-7 nicotinic acetylcholine receptor showing efficacy in the novel object recognition model of cognition enhancementJohn Skidmore, Zeenat Atcha, Emmanuelle Boucherat, et al.Pageof 2